<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>An extracellular signal, such as <z:chebi fb="0" ids="8116">phorbol</z:chebi>-12-<z:chebi fb="0" ids="30807">myristate</z:chebi>-13-<z:chebi fb="49" ids="30089,47622">acetate</z:chebi> (<z:chebi fb="1" ids="53780">PMA</z:chebi>), was found to reduce the c-myc expression in Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>) cells but augment the expression of the same gene in a B-lymphoblastoid cell line (B-LCL) </plain></SENT>
<SENT sid="1" pm="."><plain>Studies with Epstein-Barr virus (EBV)-converted <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> cells demonstrated that the differential effect of <z:chebi fb="1" ids="53780">PMA</z:chebi> on c-myc expression was not due to alterations in the structure of the translocated c-myc gene, but to the difference in the intracellular milieu of the B cells </plain></SENT>
<SENT sid="2" pm="."><plain>Experiments on the degradation rate in c-myc <z:chebi fb="40" ids="33697">RNA</z:chebi> suggested that this phenomenon in c-myc expression was exerted, at least in part, at the transcriptional level </plain></SENT>
</text></document>